<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02557230</url>
  </required_header>
  <id_info>
    <org_study_id>Ped GU Tumors</org_study_id>
    <nct_id>NCT02557230</nct_id>
  </id_info>
  <brief_title>Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience</brief_title>
  <official_title>Malignant Genito-urinary Tumors in Children: South Egypt Cancer Institute Experience</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to identify demographic &amp; disease characteristics in pediatric&#xD;
      oncology patients diagnosed with one of genitourinary tumors &amp; treatment outcomes in these&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:&#xD;
&#xD;
      Tumors of the kidney, bladder, prostate, testis, and adrenal represent a large part of the&#xD;
      adult urologic practice, but are relatively infrequent in children.&#xD;
&#xD;
      Genitourinary tumors contribute to pediatric solid tumors. Wilms tumor, rhabdomyosarcoma, and&#xD;
      germ cell tumors are the most common malignant genitourinary tumors in children.&#xD;
&#xD;
      The natural history and management of these tumors in the pediatric age is different from&#xD;
      that of the adults. As result of the successful work of several clinical trial groups in&#xD;
      recent decades, there has been a significant improvement in their cure rates.&#xD;
&#xD;
      Patients &amp; Methods:&#xD;
&#xD;
      From January 2001 till December 2015, retrieval &amp; analysis of the medical records of&#xD;
      pediatric patients with genitourinary tumors will be made at the pediatric oncology&#xD;
      department, South Egypt Cancer Institute which represents the largest referral center in&#xD;
      Upper Egypt. These data will be categorized according to demographic characteristics,&#xD;
      clinico-pathologic features, treatment modalities received, and outcomes of treatments in&#xD;
      these patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Overall survival (OS)</measure>
    <time_frame>Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years</time_frame>
    <description>Time from the date of initiation of treatment until death from any cause</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Event Free Survival (EFS)</measure>
    <time_frame>Participants will be retrospectively followed forward in time from the date of initiation of treatment till the primary completion date of the study, an expected average of 5 years</time_frame>
    <description>Time from the date of initiation of treatment until disease progression, or death for any reason.</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Genitourinary Neoplasms</condition>
  <condition>Neoplasms, Genitourinary</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Pediatric cancer patients, those diagnosed with any of genitourinary neoplasms, in the&#xD;
        period from 2001 January till 2015 December, and received treatment at the pediatric&#xD;
        oncology department, their medical records will be retrospectively reviewed for data&#xD;
        collection.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients whose age less than or equal to 18 years.&#xD;
&#xD;
          -  Patients diagnosed with any of neoplasms affecting the genitourinary system.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients whose age more than 18 years.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assiut University</name>
      <address>
        <city>Assiut</city>
        <zip>71515</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed M. Morsy, MD</last_name>
      <phone>+2 01003314522</phone>
      <email>ahmedmohammed7829@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Ahmed M. Morsy, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Khalid M. Rezk, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Badawy M. Ahmed, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ameer M. Abuelgheet, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Dénes FT, Duarte RJ, Cristófani LM, Lopes RI. Pediatric genitourinary oncology. Front Pediatr. 2013 Dec 16;1:48. doi: 10.3389/fped.2013.00048. Review.</citation>
    <PMID>24400293</PMID>
  </reference>
  <reference>
    <citation>Lambert S. Adult Survivors of Pediatric Genitourinary Tumors. In: Wood HM, Wood D, editors. Transition and Lifelong Care in Congenital Urology: Springer International Publishing; 2015. p. 209-16.</citation>
  </reference>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>September 21, 2015</study_first_submitted>
  <study_first_submitted_qc>September 21, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 23, 2015</study_first_posted>
  <last_update_submitted>July 24, 2021</last_update_submitted>
  <last_update_submitted_qc>July 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohammed Morsy, MD</investigator_full_name>
    <investigator_title>Lecturer, Pediatric Oncology Department</investigator_title>
  </responsible_party>
  <keyword>Childhood Cancer</keyword>
  <keyword>Genitourinary tumors</keyword>
  <keyword>urogenital tumors</keyword>
  <keyword>Pediatric Oncology</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Urogenital Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

